Molecular Testing of Lung Cancers

Targeted therapies guided by molecular diagnostics have become a standard treatment of lung cancer. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are currently used as the best predictive biomarkers for EGFR tyrosine kinase inhibitors and ALK i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pathol Transl Med
Main Authors: Shim, Hyo Sup, Choi, Yoon-La, Kim, Lucia, Chang, Sunhee, Kim, Wan-Seop, Roh, Mee Sook, Kim, Tae-Jung, Ha, Seung Yeon, Chung, Jin-Haeng, Jang, Se Jin, Lee, Geon Kook
Format: Artigo
Jezik:Inglês
Izdano: The Korean Society of Pathologists and the Korean Society for Cytopathology 2017
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445209/
https://ncbi.nlm.nih.gov/pubmed/28427247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2017.04.10
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki